Network analysis suggested that four shared targets may play crucial roles in the treatment of cataracts, including aldose reductase (AKR1B1), caspase-3 (CASP3), mitogen-activated protein kinase 14 (MAPK14), and estrogen receptor (ESR1). This evidence concerns the gene AKR1B1 and cataract.